MRCF has kickstarted a fifth fund to make early-stage investments in medical technologies from its network of member research institutions in Australia and New Zealand.
Queensland-founded Admedus Immunotherapies has fallen into administration after a deal with drug developer Constellation Therapeutics failed to materialise.
Uniseed, Carthona Capital and BridgeLane Group provided the funding for University of Sydney-founded Agerris, which is preparing to commercialise products including robotic farm hand systems.
QUT Bluebox has joined corporates Holland Insurance and Seven West Media in the second funding round for over-60s package holiday portal Starts at 60.
Oil and gas exploration company Woodside Energy was sufficiently intrigued in its earlier development pact with ECU-founded Sapien Cyber to purchase a 10% stake.
Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon Kids Institute with capital from an Australian government-backed initiative.